Last reviewed · How we verify

Tramadol/Diclofenac 50/50

Grünenthal GmbH · Phase 3 active Small molecule

Tramadol/Diclofenac 50/50 is a Opioid analgesic/NSAID Small molecule drug developed by Grünenthal GmbH. It is currently in Phase 3 development for Moderate to severe pain, Inflammatory pain. Also known as: Adorlan Forte (Registered Trademark).

Tramadol is a centrally acting opioid analgesic, while diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis.

Tramadol is a centrally acting opioid analgesic, while diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis. Used for Moderate to severe pain, Inflammatory pain.

At a glance

Generic nameTramadol/Diclofenac 50/50
Also known asAdorlan Forte (Registered Trademark)
SponsorGrünenthal GmbH
Drug classOpioid analgesic/NSAID
TargetOpioid receptors/COX enzymes
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 3

Mechanism of action

Tramadol works by binding to opioid receptors in the brain and spinal cord, reducing the perception of pain. Diclofenac, on the other hand, blocks the production of prostaglandins, which are chemicals that cause inflammation and pain. The combination of both drugs provides analgesic and anti-inflammatory effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tramadol/Diclofenac 50/50

What is Tramadol/Diclofenac 50/50?

Tramadol/Diclofenac 50/50 is a Opioid analgesic/NSAID drug developed by Grünenthal GmbH, indicated for Moderate to severe pain, Inflammatory pain.

How does Tramadol/Diclofenac 50/50 work?

Tramadol is a centrally acting opioid analgesic, while diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis.

What is Tramadol/Diclofenac 50/50 used for?

Tramadol/Diclofenac 50/50 is indicated for Moderate to severe pain, Inflammatory pain.

Who makes Tramadol/Diclofenac 50/50?

Tramadol/Diclofenac 50/50 is developed by Grünenthal GmbH (see full Grünenthal GmbH pipeline at /company/gr-nenthal-gmbh).

Is Tramadol/Diclofenac 50/50 also known as anything else?

Tramadol/Diclofenac 50/50 is also known as Adorlan Forte (Registered Trademark).

What drug class is Tramadol/Diclofenac 50/50 in?

Tramadol/Diclofenac 50/50 belongs to the Opioid analgesic/NSAID class. See all Opioid analgesic/NSAID drugs at /class/opioid-analgesic-nsaid.

What development phase is Tramadol/Diclofenac 50/50 in?

Tramadol/Diclofenac 50/50 is in Phase 3.

What are the side effects of Tramadol/Diclofenac 50/50?

Common side effects of Tramadol/Diclofenac 50/50 include Nausea, Dizziness, Headache, Abdominal pain, Diarrhea, Constipation.

What does Tramadol/Diclofenac 50/50 target?

Tramadol/Diclofenac 50/50 targets Opioid receptors/COX enzymes and is a Opioid analgesic/NSAID.

Related